IDT: Contract Drug Maker — The Empty Chair

IDT · ASX:Australia's only end-to-end pharmaceutical contract manufacturer is rebuilding from a deep trough — costs are down, one division is booming, and a $19 million pipeline sits waiting. But the CEO cha...
1 / 6

IDT: Contract Drug Maker — The Empty Chair

💡

In a Nutshell

Executive Summary